Influencer E-Cigarette and Cannabis Marketing: a Survey-Based Experiment Among Adolescents
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Apr 4, 2025
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
Adolescents (13-17 years of age) living in California were recruited by Tobacco Center of Regulatory Science at the University of Southern California (USC TCORS) to participate in the ADVANCE survey cohort focused on tobacco-related attitudes and behaviors. Participants completed the experiment, which was part of the survey at cohort's Wave 7, on Chromebooks in classroom. All participants provided informed consent and parental assent prior to participating in the experiment. The study was approved by the University of Southern California Institutional Review Board (HS-19-00682-AM016). Respo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English fluency,
- • Current California resident.
- Exclusion Criteria:
- Not meeting these criteria:
- • English fluency,
- • Current California resident.
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Gina Klemm
Study Director
University of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported